flutamide has been researched along with Experimental Mammary Neoplasms in 18 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (66.67) | 18.7374 |
1990's | 5 (27.78) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (5.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caceres, S | 1 |
Monsalve, B | 1 |
Peña, L | 1 |
de Andres, PJ | 1 |
Alonso-Diez, A | 1 |
Illera, MJ | 1 |
Woodward, WA | 1 |
Reuben, JM | 1 |
Silvan, G | 1 |
Illera, JC | 1 |
Le Goff, JM | 1 |
Belanger, A | 3 |
Ip, MM | 1 |
Milholland, RJ | 1 |
Kim, U | 1 |
Rosen, F | 1 |
Yates, J | 1 |
King, RJ | 1 |
Dran, G | 1 |
Luthy, IA | 4 |
Molinolo, AA | 2 |
Montecchia, F | 1 |
Charreau, EH | 1 |
Pasqualini, CD | 1 |
Lanari, C | 2 |
Boccuzzi, G | 1 |
Tamagno, E | 1 |
Brignardello, E | 1 |
Di Monaco, M | 1 |
Aragno, M | 1 |
Danni, O | 1 |
Maucher, A | 1 |
von Angerer, E | 1 |
Montecchia, MF | 1 |
Lamb, C | 1 |
Pazos, P | 1 |
Charreau, E | 1 |
Vanzulli, S | 1 |
Lu, J | 1 |
Matsumoto, K | 1 |
Nishizawa, Y | 1 |
Tanaka, A | 1 |
Hirose, T | 1 |
Sato, B | 1 |
Plante, M | 1 |
Lapointe, S | 1 |
Labrie, F | 8 |
Begin, DJ | 1 |
Dauvois, S | 2 |
Li, SM | 1 |
Martel, C | 1 |
Bégin, D | 1 |
Wing, LY | 1 |
Hammond, JO | 1 |
Brodie, AM | 1 |
Spinola, PG | 1 |
Marchetti, B | 1 |
Mérand, Y | 1 |
Luthy, I | 2 |
Simard, J | 1 |
Guay, J | 1 |
18 other studies available for flutamide and Experimental Mammary Neoplasms
Article | Year |
---|---|
In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines.
Topics: Androstenedione; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Dihyd | 2018 |
Metabolism of tritiated C19 steroids by Shionogi mouse mammary tumors.
Topics: Androgens; Androstenediols; Androstenedione; Androsterone; Animals; Castration; Dehydroepiandrostero | 1984 |
Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat.
Topics: Androgens; Animals; Castration; Cytosol; Dihydrotestosterone; Estradiol; Female; Flutamide; Male; Ma | 1982 |
Antiandrogen effects on androgen-responsive mammary tumour cells in culture.
Topics: Anilides; Animals; Cell Division; Cells, Cultured; Cyproterone; Dihydrotestosterone; Dose-Response R | 1981 |
Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
Topics: Adenocarcinoma; Androgen Antagonists; Animals; Blood Physiological Phenomena; Cell Division; Dexamet | 1995 |
Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Dihydrotestosterone; Estradiol; Female; Flutamide; Follic | 1995 |
Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1993 |
Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
Topics: Adenocarcinoma; Androgens; Animals; Binding Sites; Estradiol; Female; Flutamide; Glucocorticoids; Go | 1999 |
Non-classical androgenic actions of RU38486 in androgen-responsive Shionogi carcinoma 115 cells in serum-free culture.
Topics: Animals; Cell Division; Culture Media, Serum-Free; Dexamethasone; DNA, Neoplasm; Drug Interactions; | 1991 |
Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Topics: Androgens; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Flutamide; Male | 1988 |
Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture.
Topics: Androgens; Animals; Cell Division; Chlormadinone Acetate; Dihydrotestosterone; Flutamide; Male; Mamm | 1988 |
Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Androstenediol; Androstenediols; Androstenedion | 1989 |
Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Dihydrotestosterone; Drug Implants; Estradiol; Female; Fl | 1989 |
Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro.
Topics: Androgens; Androstenediol; Androstenediols; Androstenedione; Animals; Cell Line; Dehydroepiandroster | 1988 |
Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Dihydrotestosterone; Estradiol; Female; Flutamide; F | 1988 |
Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Anilides; Animals; Cell Division; Female; Flutami | 1988 |
Development of androgen resistance in mouse mammary tumor cells can be prevented by the antiandrogen flutamide.
Topics: Anilides; Animals; Cells, Cultured; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Resi | 1987 |
Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues.
Topics: Anilides; Animals; Cells, Cultured; Female; Flutamide; Humans; Kinetics; Male; Mammary Neoplasms, Ex | 1986 |